257 related articles for article (PubMed ID: 26085929)
1. Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.
Mao JM; Liu J; Guo G; Mao XG; Li CX
Biomark Res; 2015; 3():8. PubMed ID: 26085929
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.
Liu Y; Xu X; Zhang Y; Mo Y; Sun X; Shu L; Ke Y
Cell Death Dis; 2022 Jun; 13(6):536. PubMed ID: 35676251
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways in tumor vasculogenic mimicry.
Vartanian AA
Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.
Ayala-Domínguez L; Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Manzo-Merino J; Martínez-Ramírez I; Lizano M
Front Oncol; 2019; 9():998. PubMed ID: 31612116
[TBL] [Abstract][Full Text] [Related]
5. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
6. Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells.
Pastorino O; Gentile MT; Mancini A; Del Gaudio N; Di Costanzo A; Bajetto A; Franco P; Altucci L; Florio T; Stoppelli MP; Colucci-D'Amato L
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146471
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study.
Chen Y; Jing Z; Luo C; Zhuang M; Xia J; Chen Z; Wang Y
Med Oncol; 2012 Mar; 29(1):324-31. PubMed ID: 21161444
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Vasculogenic Mimicry in Breast Cancer.
Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
Front Oncol; 2020; 10():220. PubMed ID: 32175277
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
Rong X; Huang B; Qiu S; Li X; He L; Peng Y
Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
[TBL] [Abstract][Full Text] [Related]
10. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.
Shao R; Taylor SL; Oh DS; Schwartz LM
Oncotarget; 2015 Dec; 6(38):40507-18. PubMed ID: 26439689
[TBL] [Abstract][Full Text] [Related]
11. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway.
Zhu Y; Liu X; Zhao P; Zhao H; Gao W; Wang L
Front Pharmacol; 2020; 11():25. PubMed ID: 32116702
[TBL] [Abstract][Full Text] [Related]
12. Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.
Maddison K; Faulkner S; Graves MC; Fay M; Bowden NA; Tooney PA
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568738
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.
Fan YZ; Sun W
World J Gastrointest Surg; 2010 Apr; 2(4):117-27. PubMed ID: 21160860
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer.
Lim D; Do Y; Kwon BS; Chang W; Lee MS; Kim J; Cho JG
BMB Rep; 2020 Jun; 53(6):291-298. PubMed ID: 32438972
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis for the differences in vasculogenic activity and sensitivity to angiogenic stimulants between human glioma cells and normal endothelial cells.
Kuang XY; Ren Y; Chen C; Su J; Li HM; Liu SJ; Sun TJ; Mu DY; Lu J; Chen L; Qu HD; Cui YH; Yu AY; Yao XH
Brain Res; 2020 Dec; 1748():147082. PubMed ID: 32866544
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
17. Signalling pathways in vasculogenic mimicry.
Paulis YW; Soetekouw PM; Verheul HM; Tjan-Heijnen VC; Griffioen AW
Biochim Biophys Acta; 2010 Aug; 1806(1):18-28. PubMed ID: 20079807
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.
Huang J; Wang C; Hou Y; Tian Y; Li Y; Zhang H; Zhang L; Li W
Biomed Pharmacother; 2023 Nov; 167():115455. PubMed ID: 37696083
[TBL] [Abstract][Full Text] [Related]
19. Pseudogene MAPK6P4-encoded functional peptide promotes glioblastoma vasculogenic mimicry development.
Zhang M; Zhao Y; Liu X; Ruan X; Wang P; Liu L; Wang D; Dong W; Yang C; Xue Y
Commun Biol; 2023 Oct; 6(1):1059. PubMed ID: 37853052
[TBL] [Abstract][Full Text] [Related]
20. Histochemical Staining of Vasculogenic Mimicry.
Imani S; Liu S; Maghsoudloo M; Wen Q
Methods Mol Biol; 2022; 2514():107-120. PubMed ID: 35771423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
